Literature DB >> 20352234

Multidisciplinary treatment of giant invasive prolactinomas in paediatric age: long-term follow-up in two children.

Mario Francesco Fraioli1, Federica Novegno, Elisabetta Catena, Chiara Fraioli, Laura Moschettoni.   

Abstract

BACKGROUND: Invasive giant prolactinomas are rare tumours, still representing a therapeutic challenge due to their characteristics of invasiveness and variable clinical course. Giant prolactinomas in childhood are extremely rare. Only single case reports have been described in the literature. CASE
PRESENTATION: We report on two children who presented a progressive visual deterioration. Magnetic resonance imaging showed extensive intra-suprasellar tumour invading the anterior skull base. The laboratory investigations detected markedly elevated prolactin levels. The patients were firstly started on dopamine agonist therapy with partial reduction in size of the tumours. The debulking of the residual lesions through a transsphenoidal approach was then performed in both patients, one of whom requiring a second surgical procedure for tumour regrowth. The complete shrinkage of the residual adenomas was achieved after the treatment with conventional radiotherapy, with a follow-up of 13 and 14 years, respectively. DISCUSSION: Multidisciplinary therapeutic approach for giant prolactinomas in paediatric patients can be an effective treatment; despite the invasiveness of these tumours, the efficacy of this combined treatment can reach a satisfactory control of the disease at long term, assuring a good quality of life as well.

Entities:  

Mesh:

Year:  2010        PMID: 20352234     DOI: 10.1007/s00381-010-1129-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  26 in total

1.  Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases.

Authors:  William T Couldwell; Martin H Weiss; Craig Rabb; James K Liu; Ronald I Apfelbaum; Takanori Fukushima
Journal:  Neurosurgery       Date:  2004-09       Impact factor: 4.654

2.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.

Authors:  G Minniti; D Traish; S Ashley; A Gonsalves; M Brada
Journal:  Clin Endocrinol (Oxf)       Date:  2006-05       Impact factor: 3.478

Review 4.  Pituitary tumors in children: clinical analysis of 21 cases.

Authors:  M Mehrazin
Journal:  Childs Nerv Syst       Date:  2006-12-02       Impact factor: 1.475

5.  Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up.

Authors:  Zhe Bao Wu; Chun Jiang Yu; Zhi Peng Su; Qi Chuan Zhuge; Jin Sen Wu; Wei Ming Zheng
Journal:  J Neurosurg       Date:  2006-01       Impact factor: 5.115

6.  Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.

Authors:  G Minniti; D Traish; S Ashley; A Gonsalves; M Brada
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

Review 7.  Radiation-induced hypopituitarism.

Authors:  Alberto Fernandez; Michael Brada; Lina Zabuliene; Niki Karavitaki; John A H Wass
Journal:  Endocr Relat Cancer       Date:  2009-06-04       Impact factor: 5.678

8.  Pituitary adenomas with onset during puberty. Features and treatment.

Authors:  B Fraioli; L Ferrante; P Celli
Journal:  J Neurosurg       Date:  1983-10       Impact factor: 5.115

9.  Long-term outcomes of radiotherapy for pituitary adenomas.

Authors:  Felicia E Snead; Robert J Amdur; Christopher G Morris; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-09       Impact factor: 7.038

10.  Transmaxillosphenoidal approach to tumors invading the medial compartment of the cavernous sinus.

Authors:  B Fraioli; V Esposito; A Santoro; G Iannetti; R Giuffrè; G Cantore
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

View more
  4 in total

Review 1.  Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas.

Authors:  Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

2.  Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population.

Authors:  Farida Chentli; Said Azzoug; Katia Daffeur; Lina Akkache; Hadjer Zellagui; Meriem Haddad; Nadia Kalafate
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

3.  Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience.

Authors:  Kyung Rae Cho; Kyung-Il Jo; Hyung Jin Shin
Journal:  Brain Tumor Res Treat       Date:  2013-10-31

4.  Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup.

Authors:  Ze Rui Wu; Yong Zhang; Lin Cai; Shao Jian Lin; Zhi Peng Su; Yong Xu Wei; Han Bing Shang; Wen Lei Yang; Wei Guo Zhao; Zhe Bao Wu
Journal:  Int J Endocrinol       Date:  2016-11-23       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.